Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 53 female Rett syndrome patients ages 16-45 showed that twice-daily 35 and 70 mg/kg doses of oral NNZ-2566 for up to 28 da...